Healthcare Financial News

Warburg Pincus will acquire Everise, a leading global healthcare services outsourcing company, from its existing investor Brookfield, said a company press release. Warburg Pincus’ investment values the company at around $1 billion and Brookfield will retain a minority stake. Further details of the stake buyout is not disclosed. Warburg Pincus is in advanced negotiations to acquire Everise Holdings, a Delaware-registered outsourcing company, ET first reported on 28 July. ET first reported in May on Warburg Pincus' interest in Everise.

The Rs 640-crore IPO of Updater Services was subscribed 2.9 times overall at the close. The issue comprised fresh equity of Rs 400 crore and an offer for sale (OFS) of 80 lakh shares by promoter and other selling shareholders. The company priced the IPO in the range of Rs 280-300 per share.

type 2 diabetes at the age of 30 could see their life expectancy fall by as much as 14 years, according to a study published in The Lancet Diabetes & Endocrinology. The analysis of data from 19 high-income countries found that even people who do develop the condition at the age of 50 could see their life expectancy fall by up to six years. The findings highlight the urgent need to develop and implement interventions that prevent or delay onset of diabetes, especially as the prevalence of diabetes among younger adults is rising globally, the researchers said.

Relative Strength Index (RSI). On September 29, Friday, StockEdge reported 50 stocks that were trending up, and in this article, we will delve into the significance of RSI by examining 10 stocks handpicked by ETMarkets that have seen their RSI trending up. The Relative Strength Index (RSI) is a versatile technical indicator used by traders and investors to gauge the momentum and strength of a stock's price movements.

The US narrowly avoided a government shutdown last week following intense debates between the Democrats and Republicans over budget allocations. This confrontation follows a previous conflict concerning government expenditure, which earlier in the year had risked plunging the nation into a debt crisis. Mint looks at this latest saga and the consequences thereof.

“We expect sectors such as 1)IT, 2)Healthcare, 3)Manufacturing, and 4)Consumer Discretionary to drive the next leg of the rally, given their attractive valuations and strong fundamentals,” says Aditya Sood, Fund Manager- InCred Asset Management. In an interview with ETMarkets, Sood said: “We expect a mixed bag of earnings for the rest of the financial year; with the automobile and financials expected to perform resiliently, the earnings of cement and consumer companies are expected to be under pressure” Edited excerpts: What a week for Indian markets – 20,000 and then some profit taking in the week gone by. How are you looking at markets? At the current levels, we believe the markets are fairly valued and foresee limited scope for multiple expansions in the short term.

Vietnam, Madan Mohan Sethi highlighted the cordial and friendly relationship between India and Vietnam, emphasizing their historical ties through civilization that spans over 2,000 years. «More than 400 Indian companies, small and big have invested in Vietnam for a cumulative value of more than USD 1 billion,» he said. He mentioned that both countries have collaborated in various areas, including trade, defense, and strategic cooperation. He noted the increasing number of Indian tourists visiting Vietnam, with over 400,000 Indian tourists estimated to have visited the country in recent times.

Advent could rope in new investors into its planned combination of Suven Pharma and Cohance Life Sciences, as it looks to create a top three contract development and manufacturing organisation with a diversified shareholder base by combining the portfolio companies, according to sources in the know. «A few investors have been sounded out. They are looking to induct new investors as part of the merger plan of Suven Pharma with Cohance. The idea is to have a diversified shareholder base in the merged entity and bring in investors who could add value to the business,» a person in the know said.

malaria vaccine jointly developed by University of Oxford and Serum Institute of India (SII), leveraging Novavax's adjuvant, has been recommended for use by the World Health Organization's Strategic Advisory Group of Experts and the Malaria Policy Advisory Group, paving the way for a global roll-out soon. The R21/Matrix-M malaria vaccine is an easily deployable vaccine that can be manufactured at mass scale at a modest cost, enabling as many as hundreds of millions of doses to be supplied to countries which are suffering a significant malaria burden, according to a news release posted on the Oxford University website.

malaria vaccine jointly developed by the University of Oxford and the Serum Institute of India (SII), leveraging Novavax's adjuvant, has now been recommended for use by the World Health Organization's (WHO) Strategic Advisory Group of Experts (SAGE) and the Malaria Policy Advisory Group (MPAG), paving the way for a global roll-out soon. The R21/Matrix-M™ malaria vaccine is an easily deployable vaccine that can be manufactured at mass scale and modest cost, enabling as many as hundreds of millions of doses to be supplied to countries which are suffering a significant malaria burden.

In today’s world, the cost of healthcare continues to rise leaving many individuals and families grappling with hefty medical bills. For those without extensive financial or insurance literacy, navigating the complex healthcare landscape can be a daunting task. However, the digital age has ushered in a wealth of opportunities for consumers to leverage technology and online resources to make well-informed decisions and save on healthcare costs. Individuals can harness the power of health apps and online resources to seek medical advice, compare prices, reduce out-of-pocket expenses and make better choices as to their requirements.

Viatris Inc. (formerly Mylan Inc.), a global healthcare company, will sell its Active Pharmaceutical Ingredients (API) business in India to Hyderabad based Iquest Enterprises, stated a company statement. Iquest Enterprises is owned by Nimmagadda Prasad, Andhra Pradesh based industrialist and founder of Matrix Laboratories.

Recharge Capital, a prominent $6B thematic-first private investment firm, has announced the appointment of Margaret Wang, previously the Executive Director and Head of Bridgewater Associates Singapore, as its new Managing Partner. Wang's primary focus will be on leading the Women’s Health Strategy and overseeing the firm's operations in the APAC region from its Singapore office.

anti-TB drug Bedaquiline to other countries without the fear of litigation, with multinational pharma giant Johnson & Johnson (J&J) confirming that it will not enforce secondary patents for Bedaquiline in any of the low and middle income countries. «The decision is intended to assure current and future generic manufacturers that they may manufacture and sell high quality generic versions of SIRTURO without a concern that the Company will enforce its bedaquiline patents, provided the generic versions of SIRTURO® produced or supplied by generic manufacturers are of good quality, medically acceptable, and are used only in the 134 low- and middle-income countries,» J&J said in a statement last week.

continue as the chairman of Larsen & Toubro Employee Trust (LTET), the company's largest stakeholder. Naik had played a key role in the trust's formation in 2003, in what analysts describe as a bid to prevent the company's hostile takeover.

AstraZeneca Pharma India on Saturday said it has received an approval from the Central Drugs Standard Control Organisation (CDSCO) to import and market a medication to prevent Respiratory Syncytial virus. The company has received the approval for Palivizumab injection in single-dose vials administered through intramuscular route, it said in a statement. This innovative therapy is indicated for prevention of serious lower respiratory tract disease requiring hospitalisation caused by Respiratory Syncytial Virus (RSV) in children at high risk of RSV disease, it added.

A M Naik stepped down as the chairman of L&T Group on Saturday. He handed over the reins of the USD 23 billion conglomerate to S N Subrahmanyan at an event in Mumbai. Naik, 81, will now be the chairman of the employees trust. He will focus on increasing many philanthropic initiatives that he has been undertaking for the past few years, according to a statement. India Post unveiled a postage stamp on Naik on the occasion. Naik's attention going forward will be on his philanthropic initiatives, including the Naik Charitable Trust which focuses on education and skill-building of the underprivileged, and the Nirali Memorial Medical Trust dedicated to facilitating super speciality healthcare at subsidised cost. Naik joined the company in 1965 as a junior engineer and went on to become its Group Chairman. In the nearly three decades in leadership roles, Naik helped the company grow to its present size and stature, the statement said.

NIPER) at Gandhinagar. «The Union government has taken a holistic approach and begun the process for the development of a cost-effective, sustainable and affordable process for 16 APIs (active pharmaceutical ingredient) and two KSMs (key starting material),» he said.

Securities and Exchange Board of India (Sebi) to raise money from the primary markets. The issue comprises offer for sale (OFS) aggregating up to 14,233,964 equity shares where International Finance Corporation l, NYLIM Jacob Ballas India Fund III LLC and Resurgence PE Investments will look to divest their stakes.

semiconductor sector has witnessed growth driven by enhanced digitalisation and technology adoption across fields such as AI, IoT, healthcare, and communications. The revenue of the global semiconductor industry touched $601.7 billion in 2022, showcasing the potential for it to evolve into a trillion-dollar industry by 2030. In recent years, India's wish to establish itself as a prominent player in the global semiconductor industry has gained significant traction.

₹27 lakh this year. This amount is approximately ₹3 lakh more than the previous year when it was secured for ₹24.6 lakh by Vengeti Laxma Reddy of VLR Builders. As per a report by The Indian Express, there was a similar auction for laddu prasadam in the satellite town of Bandlaguda Jagir, which fetched a much higher price of ₹1.25 crore.